SIGRID’s Glucose Stabiliser Demonstrates Clinical Efficacy and U.S. Commercial Momentum Amid Growing Demand for Metabolic Health Solutions
Stockholm, Sweden – June 9, 2025. SIGRID, the Swedish healthtech innovator behind the patented...
Stockholm, Sweden – June 9, 2025. SIGRID, the Swedish healthtech innovator behind the patented...